18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer

AR Haug, BPT Donfack, C Trumm… - Journal of Nuclear …, 2012 - Soc Nuclear Med
90Y radioembolization (selective internal radiation therapy [SIRT]) has emerged as a
valuable therapeutic option in unresectable, chemotherapy-refractory hepatic metastases …

Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single-center experience in 81 patients

WP Fendler, H Lechner, A Todica… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The present study evaluated safety, efficacy, and prognostic factors for 90Y-yttrium
microsphere radioembolization of unresectable liver metastases from breast cancer …

Radioembolization in patients with hepatic metastases from breast cancer

TF Jakobs, RT Hoffmann, T Fischer… - Journal of Vascular and …, 2008 - Elsevier
PURPOSE: To determine the safety of and survival outcomes associated with single-
session, whole-liver radioembolization with Yttrium-90 (90Y)-labelled resin microspheres in …

Variation of liver SUV on 18FDG-PET/CT studies in women with breast cancer

D Groheux, M Delord, D Rubello… - Clinical nuclear …, 2013 - journals.lww.com
Purpose It has been proposed to use liver as reference organ when assessing tumor
response with PET. We investigated whether liver 18 FDG uptake is dependent on clinical …

Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer

WP Fendler, DBP Tiega, H Ilhan… - Journal of Nuclear …, 2013 - Soc Nuclear Med
90Y radioembolization (selective internal radiation therapy [SIRT]) is a valuable therapeutic
option for unresectable hepatic metastases arising from primary colorectal cancer. The …

The role of early 18F-FDG PET/CT in prediction of progression-free survival after 90Y radioembolization: comparison with RECIST and tumour density criteria

I Zerizer, A Al-Nahhas, D Towey, P Tait, B Ariff… - European journal of …, 2012 - Springer
Purpose This study evaluated the ability of 18 F-FDG PET/CT imaging to predict early
response to 90 Y-radioembolization in comparison with contrast-enhanced CT (CECT) using …

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival

AK Bangash, B Atassi, V Kaklamani, TK Rhee… - Journal of Vascular and …, 2007 - Elsevier
PURPOSE: To present data from patients with breast cancer liver metastases who
underwent radioembolization with yttrium (90Y) microspheres. MATERIALS AND …

Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing 90Y Radioembolization of Hepatic Metastases

A Barabasch, A Heinzel, P Bruners, NA Kraemer… - Radiology, 2018 - pubs.rsna.org
Purpose To determine the relationship between diffusion-weighted (DW) liver MR images
obtained 4–6 weeks after lobar yttrium 90 (90Y) treatment and overall survival in comparison …

Use of PERCIST for prediction of progression-free and overall survival after radioembolization for liver metastases from pancreatic cancer

M Michl, S Lehner, PM Paprottka, H Ilhan… - Journal of Nuclear …, 2016 - Soc Nuclear Med
We evaluated the prognostic accuracy of established PET response criteria in patients with
liver metastases from pancreatic cancer after treatment with 90Y microspheres. Methods …

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma

JW Lee, JC Paeng, KW Kang, HW Kwon… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Although several prognostic factors are used to predict recurrence and to select adequate
candidates for liver transplantation for hepatocellular carcinoma (HCC), these prognostic …